Immunologic effects of cyclosporine.
D000938:Antigen-Presenting Cells / Q000276:immunology; D003524:Cyclosporins / Q000009:adverse effects / Q000494:pharmacology*; D006680:HLA Antigens / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007107:Immune System / Q000187:drug effects*; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007375:Interleukin-1 / Q000276:immunology; D007376:Interleukin-2 / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D008232:Lymphoproliferative Disorders / Q000139:chemically induced; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014777:Virus Diseases / Q000209:etiology
D003524:Cyclosporins; D006680:HLA Antigens; D000949:Histocompatibility Antigens Class II; D007375:Interleukin-1; D007376:Interleukin-2